Evogene Ltd. (TLV:EVGN)
Israel
· Delayed Price · Currency is ILS · Price in ILA 411.50
-12.00 (-2.83%)
May 13, 2025, 5:24 PM IDT
Evogene Market Cap
Evogene has a market cap or net worth of 26.81 million as of May 13, 2025. Its market cap has decreased by -80.83% in one year.
Market Cap
26.81M
Enterprise Value
39.49M
Revenue
31.00M
Ranking
n/a
PE Ratio
n/a
Stock Price
411.50
Market Cap Chart
Since October 15, 2007, Evogene's market cap has decreased from 113.15M to 26.81M, a decrease of -76.31%. That is a compound annual growth rate of -7.86%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Teva Pharmaceutical Industries | 73.61B |
| Danel (Adir Yeoshua) | 2.35B |
| Kamada | 1.39B |
| Bait Bakfar | 1.16B |
| Novolog (Pharm-Up 1966) | 774.95M |
| SofWave Medical | 722.24M |
| Ilex Medical | 680.80M |
| BrainsWay | 586.43M |